| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/16/2004 | US20040180850 Polysaccharides with Helicobacter pylori receptor activity; preventing bacteria adhesion; stabilizing gastrointestinal mucus layer against ulcer causing agents |
| 09/16/2004 | US20040180843 Treatment of helicobacter with isothocyanates |
| 09/16/2004 | US20040180840 Blood brain barrier crossing and/or oral drug delivery; central nervous system tumors and cancer; such as etoposide attached to ethylene glycol oligomer or polymer; blood solubility, in vivo hydrolysis |
| 09/16/2004 | US20040180832 Sustained peptide-release formulation |
| 09/16/2004 | US20040180407 Novel G protein coupled receptor protein, DNA and its ligand |
| 09/16/2004 | US20040180100 Active ingredients preparation and single compound purification from traditional chinese herbal medicine fructus Trichosanthis and uses thereof |
| 09/16/2004 | US20040180095 Biodegradable microspheres are administered by stereotactic injection directly into the tumor, into the peritumoral area or at the same time into the tumor and the peritumoral area |
| 09/16/2004 | US20040180040 Methods and compositions for directing cells to target organs |
| 09/16/2004 | US20040180035 Administering to the mammal (i) an immunoconjugate comprising an antibody binding site capable of binding the preselected cell-type and a cytokine capable of inducing a said immune response against the preselected cell-type, and (ii) an angiogenesis inhibitor to enhance immune response |
| 09/16/2004 | US20040180001 antitumor |
| 09/16/2004 | DE20320528U1 Neue Kristallformen von Ondansetron und Arzneimittel, welche die neuen Formen enthalten New crystal forms of ondansetron and pharmaceutical compositions containing the new forms |
| 09/16/2004 | DE10310082A1 Protein-bindende Doxorubicin-Peptid-Derivate Protein-binding doxorubicin-peptide derivatives |
| 09/16/2004 | DE10307928A1 Verwendung von 1-(2-Chlorethyl)-1-nitroso-3-(2-hydroxyethyl)-urea zur Behandlung von Pankreaskarzinomen, Weichteilsarkomen, Hodentumoren, Lymphomen, Thymomen, Wilms Tumoren, Nierenkarzinomen, Melanomen, Lungentumoren, intracerebralen Metastasen, Tumoren im Kopf- und Halsbereich, und Mamma-Karzinomen Using 1- (2-chloroethyl) -1-nitroso-3- (2-hydroxyethyl) -urea for the treatment of pancreatic cancer, soft tissue sarcoma, testicular cancer, lymphoma, thymoma, Wilms tumors, renal carcinomas, melanomas, lung tumors, intracerebral metastasis, tumors in head and neck, and breast carcinomas |
| 09/16/2004 | CA2768008A1 Clostridial neurotoxins for treating uterine disorders |
| 09/16/2004 | CA2518237A1 Antitumor agents comprising a targeting portion and an immune response triggering portion |
| 09/16/2004 | CA2517970A1 Bifunctional heterocyclic compounds and methods of making and using the same |
| 09/16/2004 | CA2517850A1 Gm-95-containing antitumor effect potentiator, combined antitumor preparation and antitumor agent |
| 09/16/2004 | CA2517158A1 Modified aerolysin linked to a lung cancer binding agent and methods of use for treating lung cancer |
| 09/16/2004 | CA2517145A1 Soluble hyaluronidase glycoprotein (shasegp), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 09/16/2004 | CA2517136A1 Composition for treating hepatitis c |
| 09/16/2004 | CA2516931A1 Novel bicyclic urea derivatives useful in the treatment of cancer and other disorders |
| 09/16/2004 | CA2516624A1 2-oxo-1,3,5-perhydrotriazapine derivatives useful in the treatment of hyper-proliferative, angiogenesis, and inflammatory disorders |
| 09/16/2004 | CA2516353A1 Antineoplastic combinations comprising a rapamycin derivative and an aromatase inhibitor |
| 09/16/2004 | CA2514848A1 Use of adenosine receptor agonists in therapy |
| 09/15/2004 | EP1457492A1 Crystals of taxane derivative and process for their production |
| 09/15/2004 | EP1457490A1 5-membered N-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 09/15/2004 | EP1457205A1 Angiogenesis inhibitor |
| 09/15/2004 | EP1456653A2 Genes encoding g-protein coupled receptors and methods of use therefor |
| 09/15/2004 | EP1456651A2 Self-assembly molecules |
| 09/15/2004 | EP1456650A2 Gfats as modifiers of the p53 pathway and methods of use |
| 09/15/2004 | EP1456647A2 Methods for identifying and validating potential drug targets--- |
| 09/15/2004 | EP1456403A2 Methods of using 48149, a human aminopeptidase family member |
| 09/15/2004 | EP1456386A2 Polycistronic expression of antibodies |
| 09/15/2004 | EP1456385A2 Growth hormone fusion protein |
| 09/15/2004 | EP1456383A2 A library of modified structural genes or capsid modified particles useful for the identification of viral clones with desired cell tropism |
| 09/15/2004 | EP1456377A2 Syn3 compositions and methods |
| 09/15/2004 | EP1456365A2 Protein modification and maintenance molecules |
| 09/15/2004 | EP1456347A2 Antibodies that immunospecifically bind to blys |
| 09/15/2004 | EP1456239A2 Hybrid proteins with neuregulin heparin-binding domain for targeting to heparan sulfate proteoglycans |
| 09/15/2004 | EP1456234A2 Epitope regions of a thyrotrophin (tsh) receptor, uses thereof and antibodies thereto |
| 09/15/2004 | EP1456214A2 Improvements in pharmaceutical compositions |
| 09/15/2004 | EP1456212A1 6-aminomorphinane derivatives, method for the production and use thereof |
| 09/15/2004 | EP1456211A1 N-carbacycle monosubstituted indolocarbazoles as protein kinase inhibitors |
| 09/15/2004 | EP1456207A2 Heterocyclic acridone inhibitors of impdh enzyme |
| 09/15/2004 | EP1456205A1 Imidazoquinoline derivatives |
| 09/15/2004 | EP1456204A1 Triazolo-quinolin derivatives useful as adenosine receptor ligands |
| 09/15/2004 | EP1456203A1 Ethylene diamine derivatives and their use as orexin-receptor antagonists |
| 09/15/2004 | EP1456201A1 Benzhydryl derivatives |
| 09/15/2004 | EP1456200A1 Lactams as tachykinin antagonists |
| 09/15/2004 | EP1456199A1 Salt forms of e-2-methoxy-n-(3-(4-(3-methyl-pyridin-3-yloxy)-phenylamino)-quinazolin-6-yl)-allyl)-acetamide, its preparation and its use against cancer |
| 09/15/2004 | EP1456197A1 Piperidine-2,6-diones that are heterocyclically substituted in position 3 |
| 09/15/2004 | EP1456187A1 N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders, cancer, and other diseases |
| 09/15/2004 | EP1456184A1 Bis(cyanophenyl)methyl-triazole for use in prevention of breast cancer |
| 09/15/2004 | EP1456182A1 Pyrimidine derivatives as modulators of insuline-like growth factor-1 receptor (igf-i) |
| 09/15/2004 | EP1456180A1 3,4-diarylpyrazoles and their use in the therapy of cancer |
| 09/15/2004 | EP1456179A1 Deuterated substituted pyrazolylbenzylsulfonamides and medicaments comprising said compounds |
| 09/15/2004 | EP1456172A1 Pyrrolidine-2-ones as factor xa inhibitors |
| 09/15/2004 | EP1456171A1 Substituted cyclohexane derivatives |
| 09/15/2004 | EP1456165A1 Induction of apoptosis in cancer cells |
| 09/15/2004 | EP1456163A2 Improvements in pharmaceutical compositions |
| 09/15/2004 | EP1456160A2 Vitamin d analogues |
| 09/15/2004 | EP1455841A2 Osteopontin-related compositions and methods |
| 09/15/2004 | EP1455840A2 Treatment of human cancer with adenoviral vector expressing tnf-alpha |
| 09/15/2004 | EP1455837A1 Pharmaceutical conjugates with enhanced pharmacokinetic characteristics |
| 09/15/2004 | EP1455824A2 Lyophilized preparation containing antibodies to the egf receptor |
| 09/15/2004 | EP1455823A2 Anti-t cell immunotoxin fusion protein and its therapeutic use |
| 09/15/2004 | EP1455819A1 Individualized anti-cancer antibodies |
| 09/15/2004 | EP1455813A2 Pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung disease |
| 09/15/2004 | EP1455807A2 METHOD FOR USE OF IGF-BINDING PROTEIN FOR SELECTIVE SENSITIZATION OF TARGET CELLS i IN VIVO /i |
| 09/15/2004 | EP1455790A1 Use of pyridine-2,4-dicarboxylic acid diamides and of pyrimidine-4,6-dicarboxylic acid diamides for selective collagenase inhibition |
| 09/15/2004 | EP1455785A1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same |
| 09/15/2004 | EP1455781A1 Use of anastrozole for the treatment of post-menopausal women having early breast cancer |
| 09/15/2004 | EP1455775A2 Methods and compositions for modulating the immune system and uses thereof |
| 09/15/2004 | EP1455773A1 2-aryl-propionic acids and pharmaceutical compositions containing them |
| 09/15/2004 | EP1455772A1 Medium for radical treatment of tumors, inflammatory processes, fungal infections and other affections of the tissues, diagnostic and prophylactic and method of its implementation |
| 09/15/2004 | EP1455766A2 Thymosin alpha 1 peptide/polymer conjugates |
| 09/15/2004 | EP1455765A2 Use of protease-activated receptor-2 inhibitor in the manufacture of a medicament for treating delayed hypersensitivity |
| 09/15/2004 | EP1455760A1 Ultrapure oral fludara formulation with a fast releasing active substance |
| 09/15/2004 | EP1455700A2 Methods and compositions related to irm compounds and toll-like receptor pathways |
| 09/15/2004 | EP1351709B1 Pegylation of linkers improves antitumor activity and reduces toxicity of immunoconjugates |
| 09/15/2004 | EP1339420B1 Process for preparing aqueous extracts of plants and extracts so obtained |
| 09/15/2004 | EP1305317B1 Dihydroporphyrin derivatives and their uses |
| 09/15/2004 | EP1295878B1 Pyrazinone derivatives |
| 09/15/2004 | EP1257576B1 Vasoactive intestinal peptide analogs |
| 09/15/2004 | EP1212317B1 Indole derivatives and their use for the treatment of osteoporosis amongst other applications |
| 09/15/2004 | EP1202992B1 Ascididemin derivatives and their therapeutic applications |
| 09/15/2004 | EP1123111B1 Modulation of dna methyltransferase expression by combination therapy |
| 09/15/2004 | EP1054669B9 Use of thiadiazolo[4,3-a]pyridine derivatives |
| 09/15/2004 | EP1019398B1 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives useful for inhibition of farnesyl protein transferase |
| 09/15/2004 | EP1007095B1 CHIMERIC TOXINS COMPRISING GnRH FOR TARGETED THERAPY |
| 09/15/2004 | EP1001806B1 Cellular vesicle called ''exosome'', preparation and use thereof in immune stimulation |
| 09/15/2004 | EP0993460B1 Benzo(5,6)cyclohepta(1,2b)pyridine derivatives useful for inhibition of farnesyl protein transferase |
| 09/15/2004 | EP0986384A4 Inhibitors of protein isoprenyl transferases |
| 09/15/2004 | EP0979104B1 Sonodynamic therapy using an ultrasound sensitizer compound |
| 09/15/2004 | EP0841939B1 Therapeutic agents and autoimmune diseases |
| 09/15/2004 | EP0783579B1 Antigenic fragment of the tagA gene and methods for detecting predisposition to peptic ulceration and gastric carcinoma |
| 09/15/2004 | EP0656786B1 Use of isoflavone phyto-oestrogen extracts of soy or clover |
| 09/15/2004 | CN1529758A Novel expression vectors and uses thereof |
| 09/15/2004 | CN1529715A Highly sulfacted derivatives of K5 polysaccharide and their preparation |
| 09/15/2004 | CN1529713A Compositions and methods for therapy and diagnosis of ovarian cancer |